• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • View the Map
  • Local Data
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources

HepVu News & Updates

Stay up to date with new data, maps, infographics, blog posts, and other educational resources to help you better understand the viral hepatitis epidemic in the U.S. and its intersection with the opioid epidemic.

Read More News

May 31, 2023

Tessa Bialek and Dr. Matthew J. Akiyama on Expanding Hepatitis C Testing and Treatment in Prisons and Jails

May 12, 2023

Hepatitis Testing Day 2023

Read More

May 12, 2023

National Hispanic Hepatitis Awareness Day 2023

Read More

May 11, 2023

Día Nacional Hispano de Concientización sobre la Hepatitis 2023

Read More

April 27, 2023

Hepatitis Awareness Month Toolkit 2023

Read More

April 27, 2023

Hepatitis Awareness Month 2023

Read More

April 13, 2023

What's New in Viral Hepatitis - April 2023

Read More

Upcoming Events

Get involved and learn more by attending conferences, webinars, and other events to help you better understand the viral hepatitis epidemic in the U.S. and its intersection with the opioid epidemic. Have an upcoming viral hepatitis-related event? Email us at info@hepvu.org.

View All
Jun 21

EASL Congress 2023

Learn More
Jul 28

World Hepatitis Day

Learn More

Beyond the Map

Learn more about the Hepatitis B and Hepatitis C epidemics in the U.S.

Surveillance Status Report

Read the inaugural viral hepatitis surveillance status report that benchmarks the state of viral hepatitis surveillance in the U.S.

Learn More

View Local Data

Learn more about Hepatitis C where you live with state-specific statistics and national and regional comparison charts.

Learn More

Deeper Look: Opioids

Take a deeper look at how the ongoing opioid crisis impacts the Hepatitis C epidemic in the U.S.

Learn More

Hepatitis ABCs

Know the difference between Hepatitis A, B, and C? Learn the facts, symptoms, and who’s at risk for each disease here.

Learn More

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2023 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.